Radiological Staging of Ovarian Carcinoma

Seminars in Ultrasound, CT and MRI

Volumn 31, Issue 5, 2010, Pages 388-398

  Moyle, Penelope ^a   Addley, Helen C ^b   Sala, Evis ^b  

^a HINCHINGBROOKE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; PLATINUM COMPLEX;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; ULTRASOUND;

CARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY; RADIOGRAPHIC IMAGE ENHANCEMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958158174     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2010.07.003     Document Type: Article

References (49)

1. Permuth-Wey J., Sellers T.A. Epidemiology of ovarian cancer. Methods Mol Biol 2009, 472:413-437.
2. Cancer facts and figures 2009 American Cancer Society, Accessed July 23, 2010. http://www.scribd.com/doc/21686287/Cancer-Facts-and-Figures-Report-2009.
3. Pathology and genetics, in Tumours of the Breast and Female Genital Organs: Who Classification of Tumour 2003, 12. WHO, Geneva. F.A. Travassoli, T. Devilee (Eds.).
4. Suh-Burgmann E. Long term outcomes following conservative surgery for borderline tumour of the ovary: A large population based study. Gynecol Oncol 2006, 13:841-847.
5. Woodward P.J., Hosseinzadeh K., Saenger J.S. From the archives of the AFIP: Radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics 2004, 24:225-246.
6. Holschneider C.H., Berek J.S. Ovarian cancer: Epidemiology, biology, and prognostic factors. Semin Surg Oncol 2000, 19:3-10.
7. Royal College of Radiologists (RCR) making the best use of clinical radiology services 2007, Vol. 9. RCR, London.
8. Tempany C.M., Zou K.H., Silverman S.G., et al. Staging of advanced ovarian cancer: Comparison of imaging modalities-Report from the Radiological Diagnostic Oncology Group. Radiology 2000, 215:761-767.
9. Forstner R., Hricak H., Occhipinti K.A., et al. Ovarian cancer: Staging with CT and MR imaging. Radiology 1995, 197:619-626.
10. Amendola M.A. The role of CT in the evaluation of ovarian malignancy. Crit Rev Diagn Imaging 1985, 24:329-368.
11. Kalovidouris A., Gouliamos A., Pontifex G., et al. Computed tomography of ovarian carcinoma. Acta Radiol Diagn (Stockh) 1984, 25:203-208.
12. Sanders R.C., McNeil B.J., Finberg H.J., et al. A prospective study of computed tomography and ultrasound in the detection and staging of pelvic masses. Radiology 1983, 146:439-442.
13. Shiels R.A., Peel K.R., MacDonald H.N., et al. A prospective trial of computed tomography in the staging of ovarian malignancy. Br J Obstet Gynaecol 1985, 92:407-412.
14. Halvorsen R.A., Panushka C., Oakley G.J., et al. Intraperitoneal contrast material improves the CT detection of peritoneal metastases. AJR Am J Roentgenol 1991, 157:37-40.
15. Kambadakone A.R., Sahani D.V. Body perfusion CT: Technique, clinical applications, and advances. Radiol Clin North Am 2009, 47:161-178.
16. Froehlich J.M., Daenzer M., von Weymarn C., et al. Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol 2009, 19:1387-1393.
17. Hricak H., Chen M., Coakley F.V., et al. Complex adnexal masses: Detection and characterization with MR imaging-multivariate analysis. Radiology 2000, 214:39-46.
18. Sohaib S.A., Sahdev A., Van Trappen P., et al. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol 2003, 180:1297-1304.
19. Thomassin-Naggara I., Bazot M., Daraï E., et al. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 2008, 248:148-159.
20. Funt S.A., Hricak H. Ovarian malignancies. Top Magn Reson Imaging 2003, 14:329-337.
21. Fujii S., Matsusue E., Kanasaki Y., et al. Detection of peritoneal dissemination in gynecological malignancy: Evaluation by diffusion-weighted MR imaging. Eur Radiol 2008, 18:18-23.
22. Sala E., Priest A.N., Kataoka M., et al. Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: Technical development. Eur Radiol 2010, 20:491-496.
23. Cui Y., Zhang X.P., Sun Y.S., et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008, 248:894-900.
24. Kawahara K., Yoshida Y., Kurokawa T., et al. Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography. J Comput Assist Tomogr 2004, 28:505-516.
25. Grab D., Flock F., Stöhr I., et al. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol 2000, 77:454-459.
26. Gu P., Pan L.L., Wu S.Q., et al. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: A systematic review and meta-analysis. Eur J Radiol 2009, 71:164-174.
27. Iyer V.R., Lee S.I. MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol 2010, 194:311-321.
28. Nam E.J., Yun M.J., Oh Y.T., et al. Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol 2010, 116:389-394.
29. Benedet J.L., Bender H., Jones H., et al. FIGO staging and clinical practical guidelines in the management of gynaecological cancers. FIGO Committee on Gynaecologic Oncology. Int J Gynecol Obstet 2000, 70:209-262.
30. TNM Classification of Malignant Tumours Ovary (ICD-O C56) 2009, Wiley-Blackwell. Ed 7. L. Sobin, M. Gospodarowicz, C. Wittekind (Eds.).
31. Marsden D.E., Friedlander M., Hacker N.F. Current management of epithelial ovarian carcinoma: A review. Semin Surg Oncol 2000, 19. 11-11.
32. Hoskins W.J., Bundy B.N., Thigpen J.T., et al. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study. Gynecol Oncol 1992, 47:159-166.
33. Young R.C., Decker D.G., Wharton J.T., et al. Staging laparotomy in early ovarian cancer. JAMA 1983, 250:3072-3307.
34. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effects of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002, 20:1248-1259.
35. Coakley F.V., Choi P.H., Gougoutas C.A., et al. Peritoneal metastases: Detection with spiral CT in patients with ovarian cancer. Radiology 2002, 223:495-499.
36. Feldman G.B., Knapp R.C. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am J Obstet Gynecol 1974, 119:991-994.
37. Buy J.N., Moss A.A., Ghossain M.A., et al. Peritoneal implants from ovarian tumors: CT findings. Radiology 1988, 169:691-694.
38. Coakley F.V., Hricak H. Imaging of peritoneal and mesenteric disease: Key concepts for the clinical radiologist. Clin Radiol 1999, 54:563-574.
39. Tempany C.M., Zou K.H., Silverman S.G., et al. Staging of advanced ovarian cancer: Comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group. Radiology 2000, 215:761-767.
40. Griffin N., Grant L., Freeman S.J., et al. Image-guided biopsy in patients with suspected ovarian carcinoma: A safe and effective technique?. Eur Radiol 2009, 19:230-235.
41. Levy A.D., Shaw J.C., Sobin L.H. Secondary tumors and tumor like lesions of the peritoneal cavity: Imaging features with pathologic correlation. RadioGraphics 2009, 29:347-373.
42. Mitchell D.G., Hill M.C., Hill S., et al. Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology 1986, 158:649-652.
43. Moran B.J., Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003, 12:585-603.
44. Okada S., Ohaki Y., Inoue K., et al. Calcifications in mucinous and serous cystic ovarian tumors. J Nippon Med Sch 2005, 72:29-33.
45. Burkill G.J., Allen S.D., A'Hern R.P., et al. Significance of tumour calcification in ovarian carcinoma. Br J Radiol 2009, 82:640-644.
46. Tangjitgamol S., Manusirivithaya S., Sheanakul C., et al. Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma?. Int J Gynecol Cancer 2003, 13:297-302.
47. Kawamoto S., Urban B.A., Fishman E.K. Of epithelial ovarian tumors. Radiographics 1999, 19:S85-S102.
48. Chan J.K., Urban R., Hu J.M., et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: A study of 13918 patients. Br J Cancer 2007, 96:1817-1822.
49. Benedetti Panici P., Maggioni A., Hacker N., et al. Systemic aortic and pelvic lymphadenopathy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomised clinical trial. J Natl Cancer Inst 2005, 97:560-566.